Body: Our latest District Strategic Plan is in motion! We are focusing on data-driven missions and community-driven approaches to reduce crime in Calumet. Concentrated Patrols: Increasing visibility in key areas. Community Partnerships: Collaborating with local leaders and the Alderman’s office for better neighborhood lighting and resources. Get Involved: Contact the 5th District CAPS office at (312) 747-8210 to learn about local safety meetings. Stay safe and stay informed! #ChicagoPolice #District5 #SafetyFirst Option 3: Recruitment & "Join CPD" Headline: It Starts With You: Join the 005th District Team! 👮♂️
If you are looking for specific records or want to visit the 005th District station, it is located in the Calumet neighborhood. : 727 E. 111th St., Chicago, IL 60628 Phone : (312) 747-8210 Website : CPD 5th District - Calumet Alternative Meanings
The 005th District serves neighborhoods on Chicago's South Side, including Roseland, Pullman, and West Pullman. Stories from this district often involve a mix of high-stakes critical incidents and deep community engagement efforts. cpd-005
: Recently, the CPD has faced intense scrutiny over fatal incidents involving officers from South Side districts. For example, in June 2025, Officer Krystal Rivera (from the neighboring 6th District) was fatally shot by her partner during a chase in the Chatham neighborhood. Newly released body-camera footage from April 2026 shows the chaotic moments of the shooting and has sparked a wrongful death lawsuit, highlighting the ongoing risks of "friendly fire" in high-pressure tactical situations.
: The Chicago Alternative Policing Strategy (CAPS) program holds regular meetings in the 5th District to discuss local safety concerns. Body: Our latest District Strategic Plan is in motion
If you can provide a little more context—such as whether this is:
The significance of a compound like CPD-005 lies in its . In pharmaceutical development, the "ideal" drug binds only to its intended target (like a specific receptor in the brain) without affecting other parts of the body. these compounds are currently in the
As of May 2026, these compounds are currently in the , meaning they are being tested in laboratory settings to determine if they are safe enough for human trials.